Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
View ORCID ProfileThomas Mason, View ORCID ProfileMatt Whitston, View ORCID ProfileJack Hodgson, View ORCID ProfileRuth E Watkinson, View ORCID ProfileYiu-Shing Lau, View ORCID ProfileOmnia Abdulrazeg, View ORCID ProfileMatt Sutton
doi: https://doi.org/10.1101/2021.04.19.21255461
Thomas Mason
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Head of Activity Analysis
Matt Whitston
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Senior Analytical Manager
Jack Hodgson
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Analytical Officer
Ruth E Watkinson
2Health Organisation, Policy & Economics, School of Health Sciences, University of Manchester, UK
Roles: Research Associate
Yiu-Shing Lau
2Health Organisation, Policy & Economics, School of Health Sciences, University of Manchester, UK
Roles: Research Fellow
Omnia Abdulrazeg
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Senior Analytical Manager
Matt Sutton
2Health Organisation, Policy & Economics, School of Health Sciences, University of Manchester, UK
Roles: Professor
Data Availability
Data used in the study are not publicly available and may be obtained via NHS Digital (https://digital.nhs.uk/services/data-access-request-service-dars). The analysis scripts used for the evaluation are available at https://github.com/NHSEI-Analytics/nhs_covid19_effectiveness.
https://github.com/NHSEI-Analytics/nhs_covid19_effectiveness
Posted April 22, 2021.
Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
Thomas Mason, Matt Whitston, Jack Hodgson, Ruth E Watkinson, Yiu-Shing Lau, Omnia Abdulrazeg, Matt Sutton
medRxiv 2021.04.19.21255461; doi: https://doi.org/10.1101/2021.04.19.21255461
Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
Thomas Mason, Matt Whitston, Jack Hodgson, Ruth E Watkinson, Yiu-Shing Lau, Omnia Abdulrazeg, Matt Sutton
medRxiv 2021.04.19.21255461; doi: https://doi.org/10.1101/2021.04.19.21255461
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2957)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4603)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4380)
- Nursing (237)
- Nutrition (640)
- Oncology (2281)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1198)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1536)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)